CID 122650693

Risvodetinib

Structural Information

Molecular Formula
C33H34N8O2
SMILES
CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CC(=CN=C5)C6=C(C=NO6)C
InChI
InChI=1S/C33H34N8O2/c1-22-4-9-28(37-32(42)25-7-5-24(6-8-25)21-41-14-12-40(3)13-15-41)17-30(22)39-33-35-11-10-29(38-33)26-16-27(20-34-19-26)31-23(2)18-36-43-31/h4-11,16-20H,12-15,21H2,1-3H3,(H,37,42)(H,35,38,39)
InChIKey
ADGOPPKEIZXKAZ-UHFFFAOYSA-N
Compound name
N-[4-methyl-3-[[4-[5-(4-methyl-1,2-oxazol-5-yl)pyridin-3-yl]pyrimidin-2-yl]amino]phenyl]-4-[(4-methylpiperazin-1-yl)methyl]benzamide
Related CIDs

2D Structure

compound 2d structure
1
Annotation Hits

0
References

13
Patents

574.28046 Da
Monoisotopic Mass

4.0
XlogP (predicted)

Profile

Predicted Collision Cross Section

Adduct m/z Predicted CCS (Ų)
[M+H]+ 575.28774 240.9
[M+Na]+ 597.26968 244.6
[M-H]- 573.27318 251.9
[M+NH4]+ 592.31428 234.5
[M+K]+ 613.24362 235.7
[M+H-H2O]+ 557.27772 223.6
[M+HCOO]- 619.27866 251.5
[M+CH3COO]- 633.29431 243.9
[M+Na-2H]- 595.25513 238.2
[M]+ 574.27991 238.1
[M]- 574.28101 238.1
m/z: mass to charge ratio of the adduct.
Predicted Collision Cross Section (CCS) values (Ų) per adduct calculated using CCSbase.

Literature stripe

No literature data available for this compound.

Patent stripe

patents stripe